GlassScriptPhysician profile
Landon Erickstad
NPI 1457642282
$2,662.09
in general payments reported to CMS, 2019-2025
35 companies · $645 in 2025
The $645 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $86.47 · 2021: $105 · 2022: $428 · 2023: $514 · 2024: $741 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,814 · Education: $86.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.62 |
| Education | $86.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $285.53 | 2023-2025 | Gemtesa |
| Teleflex LLC | $263.19 | 2019-2025 | Urolift |
| Abbvie INC. | $224.88 | 2020-2025 | |
| Tolmar, INC. | $168.12 | 2023-2025 | Eligard, Jatenzo, Rubraca |
| Axonics, INC. | $166.44 | 2022-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $152.97 | 2022-2025 | Erleada |
| Ferring Pharmaceuticals INC. | $152.62 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $132.22 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Tria Firm |
| Astellas Pharma US INC | $117.07 | 2020-2025 | Xtandi, Veozah, Myrbetriq |
| Accord Healthcare, INC. | $88.38 | 2022-2024 | |
| Urovant Sciences INC | $69.04 | 2022 | |
| Allergan, INC. | $66.06 | 2019-2022 | |
| Procept Biorobotics Corporation | $63.53 | 2024-2025 | Aquabeam System |
| Immunitybio, INC. | $59.21 | 2025 | |
| Inspire Medical Systems, INC. | $56.90 | 2024-2025 | Inspire |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argon Medical Devices, INC. | $49.18 | 2024 | Clot Management |
| Blue Earth Diagnostics | $44.60 | 2019-2022 | |
| Rochester Medical Corporation | $43.71 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $43.10 | 2020-2022 | |
| Hollister Incorporated | $42.26 | 2022-2023 | Onli, Infyna Chic, Vapro |
| 180 Medical, INC. | $38.32 | 2019-2025 | |
| Vertex Pharmaceuticals Incorporated | $37.07 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $36.07 | 2019 | |
| Myovant Sciences INC. | $34.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.90 | 2025 | |
| Convatec INC. | $31.71 | 2023 | |
| Myriad Genetic Laboratories, INC. | $23.59 | 2025 | Prolaris |
| Urogen Pharma, INC. | $22.54 | 2025 | |
| Alnylam Pharmaceuticals INC. | $21.97 | 2023 | Oxlumo |
| Endo Pharmaceuticals INC. | $18.67 | 2023 | Aveed, Xiaflex |
| Pharmaand Gmbh | $16.95 | 2025 | Rubraca |
| Pfizer INC. | $16.12 | 2025 | |
| Laborie Medical Technologies Corp. | $15.16 | 2022 | |
| Civco Medical Instruments | $14.80 | 2025 | |
| Neotract INC. | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Landon Erickstad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.